Q1 2026 Management View Kim Kelderman, CEO, President & Director, reported that organic revenue declined 1% in Q1, ...

By combining stem cell expertise with SGAustria's encapsulation platform, the companies aim to produce safe solutions.

Oncologists' experience with CGT has increased, with more patients treated and earlier lines of therapy being utilized.

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, remain a ...

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...

Community-based CAR T-cell therapy improves access, reducing travel burdens and hospital admissions for patients with blood ...

By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of the medicinal product.

TIL therapy uses a patient’s own immune cells to attack cancer cells. The process involves extracting cells from their tumor, ...